RecruitingHealthy Volunteers, Pulmonary Arterial Hypertension
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Eligible age
18–100 yrs
Accepts
All genders
Locations
15 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)
Sponsor: Novartis Pharmaceuticals
Where it's recruiting
Arizona
Scottsdale
California
Orange · Stanford
Colorado
Aurora
Florida
Orlando · Tampa
Georgia
Atlanta
Kansas
Kansas City
Kentucky
Louisville
Massachusetts
Boston · Burlington
Mississippi
Ridgeland
Oregon
Bend
Pennsylvania
Pittsburgh
Tennessee
Knoxville
Source: ClinicalTrials.gov · NCT06649110 · last updated 2026-04-29